Increase in serum creatinkinase values following intramuscular injection;Elevacion de las concentraciones sericas de creatincinasa tras inyeccion intramuscular

Medicina Clinica

Volumn 107, Issue 17, 1996, Pages 649-654

  Montero Pérez, F Javier ^a,b   Munoz Avila J ^a   Berlango Jimenez A ^a   Duran Serantes M ^a   Calderon De La Barca Vazquez J M ^a   Jimenez Murillo L ^a   Torres Murillo, J ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLORAZEPATE DIPOTASSIUM; CLORAZEPATE POTASSIUM; CREATINE KINASE; DEXCHLORPHENIRAMINE MALEATE; DICLOFENAC; DIPYRONE; DIPYRONE MAGNESIUM; HALOPERIDOL; KETAZOLAM; KETOROLAC; METHYLPREDNISOLONE; METOCLOPRAMIDE; PETHIDINE; SCOPOLAMINE BUTYL BROMIDE; SULPIRIDE; THIAMINE; TRAMADOL; DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME BLOOD LEVEL; FEMALE; GLUTEUS MAXIMUS MUSCLE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; OSMOLARITY; PREDICTION; RANDOMIZED CONTROLLED TRIAL; BLOOD; MIDDLE AGED; PROSPECTIVE STUDY; SINGLE BLIND PROCEDURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CREATINE KINASE; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 0029959312     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Konikoff F, Halevy J, Theodor E. Serum creatine kinase after intramuscular injections. Postgrad Med J 1985; 61: 595-598.
2. a ed. esp.). Madrid: McGraw-Hill-Interamericana de España, 1994; 1.229-1.241.
3. Nevins MA, Saran M, Bright M, Lyon LJ. Pitfalls in interpreting serum creatine phosphokinase activity. JAMA 1973; 224: 1.382.
4. Meltzer HY, Mrozak S, Boyer M. Effect of intramuscular injections on serum creatine phosphokinase activity. Am J Med Sci 1970; 259: 42.
5. Cacace L. Elevated serum CPK after drug injections. N Engl J Med 1972; 287: 309.
6. Greenblatt DJ, Duhme DW, Koch-Weser J. Pain and CPK elevation after intramuscular digoxin. N Engl J Med 1973; 288: 689.
7. Zener JC, Harrison DC. Serum enzyme values following intramuscular administration of lidocaine. Arch Intern Med 1974; 134: 48-49.
8. Andersen KE, Damsgaard T. The effect on serum enzymes of intramuscular injections of digoxin, bumetanide, pentazocine and isotonic sodium chloride. Acta Med Scand 1976; 199: 317-319.
9. Surber C, Dubach UC, Forgó I. Veränderung der Kreatinkinase-Aktivität im serum nach intramuskulärer injektion. Klin Wochenschr 1988; 66: 96-102.
10. Batsakis JG, Preston JA, Briere RO, Giesen PC. latrogenic aberrations of serum enzyme activity. Clin Biochem 1968; 2: 125-133.
11. Hernández A, Rayo I, LaFuente C. Cómo interpretar la elevación de la enzima CPK. Cardiología & Hipertensión 1990; 1: 209-210.
12. Hess JW, MacDonald RP, Frederick RJ, Jones RN, Neely J, Gross D. Serum creatine phosphokinase (CPK) activity in disorders of heart and skeletal muscle. Ann Intern Med 1964; 61: 1.015-1.028.
13. Dawson DM, Fine IH. Creatine kinase in human tissues. Arch Neurol 1967; 16: 175-180.
14. a ed. esp.). Madrid: Emalsa S.A., 1986; 2.599-2.621.
15. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolisis. Medicine (Baltimore) 1982; 61: 141-152.
16. Sidell FR, Donald MAJ, Culver L, Kaminskis A. Serum creatine phosphokinase activity after intramuscular injection. The effect of dose, concentration and volume. JAMA 1974; 229: 1.894-1.897.
17. Shintani S, Yamazaki M, Nakamura M, Nakayama I. A new method to determine the irritation of drugs after intramuscular injection in rabbits. Toxicol Appl Pharmacol 1967; 11: 293-301.
18. Svendsen O. Intramuscular injections and local muscle damage: an experimental study of the effect of injection speed. Acta Pharmacol Toxicol 1983; 52: 305-309.
19. Azzam Z, Krivoy N, Alroy G, Zinder O. Serum creatine kinase levels after a single intramuscular injection-dependence on injection volume. Ann Clin Biochem 1994; 31: 193-194.
20. Svendsen O. Local muscle damage and oily vehicles. A study on local reactions in rabbits after intramuscular injection of neuroleptic drugs in aquerous or oily vehicles. Acta Pharmacol Toxicol 1983; 52: 298-304.
21. Oshida S, Degawa K, Takahashi Y, Akaishi S. Physico-chemical properties and local toxic effects of injectables. Tohoku J Exp Med 1979; 127: 301-316.
22. Steiness EF, Rasmussen F, Svendsen O, Nielsen P. A comparative study of serum creatine phosphokinase (CPK) activity in rabbits, pigs and humans after intramuscular injection of local damaging drugs. Acta Pharmacol Toxicol 1978; 42: 357-364.
23. Klein MS, Shell WE, Sobel BE. Serum creatine phosphokinase (CPK) isoenzymes following intramuscular injections, surgery and myocardial infarction. Experimental and clinical studies. Cardiovasc Res 1973; 7: 412.
24. Warnock DG, Ellman GL. Intramuscular chlorpromazine and creatine phosphokinase; acute psychoses or local trauma? Science 1969; 164; 726-727.
25. Knisch AK, Gralla EJ. Abnormal serum transaminase levels after parenteral ampicilin and carbenicillin administration. N Engl J Med 1970; 282: 1.081.
26. Hess JW, Mac Donald RP, Natho JW, Murdock KJ. Serum creatine phosphokinase. Clin Chem 1967; 13: 994-995.
27. Sobel BE, Shell WE. Serum enzime determinations in the diagnosis and assessment of myocardial intarction. Circulation 1972; 45: 471-482.
28. Svendsen O, Rasmussen F, Nielsen P, Steiness E. The loss of creatine phosphokinase (CK) from intramuscular injection sites in rabbits. A predictive tool for local toxicity. Acta Pharmacol et Toxicol 1979; 44: 324-328.
29. Svendsen O, Højelse F, Bagdon RE. Tests for local toxicity of intramuscular drug preparations: comparison of in vivo and in vitro methods. Acta Pharmacol Toxicol 1985; 56: 183-190.
30. Walker RM, Brown RS, Stoff JS. Role of renal prostaglandins during antidiuresis and water diuresis in man. Kidney Int 1981; 21: 365-370.
31. Allon M, Pasque CB, Rodríguez M. Interaction of captopril and ibuprofen on glomerular and tubular function in humans. Am J Physiol 1990; 28: 233-238.
32. Fernández-Solá J, Grau JM, Pedro-Botet JC, Casademont J, Estruch R, Company X et al. Rabdomiólisis no traumática: análisis clínico y morfológico de 53 casos. Med Clin (Barc) 1988; 90: 199-202.
33. Kageyama Y. Rhabdomyolisis; clinical analysis of 20 patients. Nippon Jinzo Gakkai Shi 1989; 31: 1.099-1.103.
34. Pascual JM, Gorriz JL, Prosper M, Collado A, Belda A, Michavila J. Rabdomiólisis aguda. Estudio de 44 casos. Rev Clin Esp 1990; 187: 6-9.
35. Ellinas PA, Rosner F. Rhabdomyolysis: report of eleven cases. J Natl Med Assoc 1992; 84: 617-624.
36. Smith K, Halliwell RM, Lawrence S, Klineberg PL, O'Connell P. Acute renal failure associated with intramuscular ketorolac. Anaesth Intens Care 1993; 21: 700-702.
37. Phillips G. Intramuscular ketorolac. Anaesth Intens Care 1994; 22: 113.
38. Young GP, Hedges JR, Gibier WB, Green TR, Swanson R. Do CK-MB results affect chest pain decision making in the emergency department? Ann Emerg Med 1991; 20: 1.220-1.228.
39. Hedges JR, Kobernick MS. Detection of myocardial ischemia/infarction in the emergency department patient with chest discomfort. Emerg Med Clin North Am 1988; 6: 317-340.
40. Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on quantitative analysis. Ann Intern Med 1986; 105: 221-233.
41. Lee TH, Weisberg MC, Cook EF, Daley K, Brand DA, Goldman L. Evaluation of creatin kinase and creatin kinase-MB for diagnosing myocardial infarction. Clinical impact in the emergency room. Arch Intern Med 1987; 147: 115-121.
42. Latour Pérez J, Álvarez do Barrio M, Estellés Herrero MA, Graells Ferrer ML. La creatincinasa (CK) total, la CK-2 y la mioglobina en el diagnóstico de infarto agudo de miocardio en un Servicio de Urgencias. Med Clin (Barc) 1993; 100: 641-645.